Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical Industries Limited (DE:TEV)
NYSE:TEV
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 17.26B | $ 16.54B | $ 15.85B | $ 14.93B | $ 15.88B |
| Gross Profit | $ 8.94B | $ 8.06B | $ 7.64B | $ 6.97B | $ 7.59B |
| Operating Income | $ 2.16B | $ -303.00M | $ 433.00M | $ -2.20B | $ 1.72B |
| EBITDA | $ 3.14B | $ 4.43B | $ 1.56B | $ -925.00M | $ 4.41B |
| Net Income | $ 1.41B | $ -1.64B | $ -559.00M | $ -2.45B | $ 417.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.56B | $ 3.30B | $ 3.23B | $ 2.80B | $ 2.17B |
| Total Assets | $ 40.75B | $ 39.33B | $ 43.48B | $ 44.01B | $ 47.67B |
| Total Debt | $ 17.38B | $ 18.08B | $ 20.15B | $ 21.56B | $ 23.46B |
| Net Debt | $ 13.83B | $ 14.78B | $ 16.93B | $ 18.76B | $ 21.29B |
| Total Liabilities | $ 32.83B | $ 33.61B | $ 35.35B | $ 35.41B | $ 36.42B |
| Stockholders' Equity | $ 7.91B | $ 5.37B | $ 7.51B | $ 7.80B | $ 10.28B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.15B | $ 749.00M | $ 842.00M | $ 1.04B | $ 236.00M |
| Operating Cash Flow | $ 1.65B | $ 1.25B | $ 1.37B | $ 1.59B | $ 798.00M |
| Investing Cash Flow | $ 737.00M | $ 792.00M | $ 968.00M | $ 656.00M | $ 1.52B |
| Financing Cash Flow | $ -2.15B | $ -1.79B | $ -1.91B | $ -1.49B | $ -2.17B |